FOCAL SEIZURE
Clinical trials for FOCAL SEIZURE explained in plain language.
Never miss a new study
Get alerted when new FOCAL SEIZURE trials appear
Sign up with your email to follow new studies for FOCAL SEIZURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to curb focal seizures in adults
Disease control Recruiting nowThis phase 3 study tests whether an investigational drug called RAP-219 can safely reduce the number of focal seizures in adults with epilepsy. About 312 participants will take either a low or medium dose of RAP-219 or a placebo pill daily. The main goal is to see if the drug low…
Matched conditions: FOCAL SEIZURE
Phase: PHASE3 • Sponsor: Rapport Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New epilepsy drug RAP-219 enters final testing phase
Disease control Recruiting nowThis study tests an experimental drug called RAP-219 in 333 adults with focal seizures (a type of epilepsy). The goal is to see if the drug safely reduces how often seizures happen compared to a placebo. Participants must be 18-75, have had focal epilepsy for at least 2 years, an…
Matched conditions: FOCAL SEIZURE
Phase: PHASE3 • Sponsor: Rapport Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for tough seizures: Long-Term safety trial launches
Disease control Recruiting nowThis study tests the long-term safety of an experimental drug called RAP-219 in 30 adults whose focal seizures do not respond well to current treatments. Participants must have already completed a related earlier study. The goal is to see if RAP-219 remains safe and helps reduce …
Matched conditions: FOCAL SEIZURE
Phase: PHASE2 • Sponsor: Rapport Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC